# Oncoustics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oncoustics

- Industry: Healthcare IT
- Headquarters: Toronto, Canada
- Website: www.oncoustics.com
- Total disclosed funding: $5M
- Latest round: Seed (Jul 21, 2022)
- Investors on record: 4

## About

Founded in 2018 and based in Ontario, Canada, Oncoustics is a provider of liver diagnosis and screening solutions for prevention and early intervention. In July 2022, Oncoustics raised USD 5 million in Seed funding from Creative Ventures, Saltagen Ventures, NorthSpring Capital Partners, and Pallasite Ventures. Ahmed El Kaffas is the founder, and Beth Rogozinski is the CEO of the company.

The company provides liver diagnosis and screening solutions, including a 5-minute exam that can be performed by any clinician or clinical staff member. The firm offers a suite of disease and anatomy-specific apps that work on any PoC ultrasound. Oncoustics' AI Solutions transform point-of-care ultrasound devices into diagnostic tools for disease detection and monitoring, such as diseases of the liver, prostate, kidney, breast, and thyroid.

The organization plans to use the July 2022 funding to support innovations in ultrasound and address huge unmet clinical needs in liver disease.

## Funding rounds

- Seed, Jul 21, 2022, $5M — Pallasite Ventures, Creative Ventures, NorthSpring Capital Partners, Saltagen Ventures

## Investors

- Pallasite Ventures (https://capitalatlas.ai/funds/pallasite-ventures) — Seed
- Creative Ventures (https://capitalatlas.ai/funds/creative-ventures) — Seed
- NorthSpring Capital Partners — Seed
- Saltagen Ventures (https://capitalatlas.ai/funds/saltagen-ventures) — Seed